Safety and Immunogenicity of a Toddler Dose Following an Infant Series of a Hexavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzaeType b, Hepatitis B Vaccine Administered Concurrently or at Separate Visits With a Heptavalent Pneumococcal Conjugate Vaccine

Autor: Halperin, Scott A., Tapiéro, Bruce, Dionne, Marc, Meekison, William, Diaz-Mitoma, Francisco, Zickler, Paul, Rubin, Earl, Embree, Joanne, Bhuyan, Prakash, Lee, Andrew, Li, Minran, Tomovici, Antigona
Zdroj: The Pediatric Infectious Disease Journal; January 2014, Vol. 33 Issue: 1 p73-80, 8p
Abstrakt: Combination diphtheria-tetanus-5 component acellular pertussis-inactivated poliovirus-Haemophilus influenzaeb conjugate-hepatitis B vaccine (DTaP5-IPV-Hib-HepB) administered either concurrently with 7-valent pneumococcal conjugate vaccine (PCV7) or 1 month apart was generally safe and immunogenic at 2, 4 and 6 months of age. This study examined the effects of a booster dose at age 15 months.
Databáze: Supplemental Index